Form 4 for STLN Starling Oncology, Inc.
Accepted 2025-07-28 00:00:00 ET · period of report 2025-07-24 · accession 0000935836-25-000475 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-07-28 | 2025-07-24 | STLN | BARASCH RICHARD A | Dir | J - Other | $0.00 | -287.8K | 2.64M | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-24 | J | D | 287,756 | $0.00 | 2,635,881 | I By LLC | — | — | (F2) The distributed shares were owned by RAB Ventures, an entity controlled by the reporting person. |